| Blog Summary |
|---|
| Fever during the post-monsoon months can be caused by influenza, COVID-19 or dengue, and their early symptoms often overlap. This blog explains how to distinguish these infections through clinical symptoms and blood count findings, when to use specific diagnostic tests, why dengue requires closer monitoring as the fever subsides, and how their treatment and prevention strategies differ. |
Flu COVID and Dengue Symptoms overlap so closely in the first two or three days that the cause often cannot be named in clinical practice. Fever, headache, body ache and fatigue are shared by all three, and the clinicians rarely have a test result at that first visit. On top of that the post-monsoon months make it harder, because all three circulate together. Delhi’s municipal report listed 1,083 dengue cases till October 31st 2026.
A wrong first guess therefore carries a real cost. Dengue that is mistaken for a routine viral fever can be missed just when it worsens, and influenza, or COVID-19 in a higher-risk patient, may reach treatment only after the period in which an antiviral helps most. So, the question to be asked is which findings should move suspicion in one direction, and when will a test actually change the plan.
When flu vs COVID vs dengue is compared at the first visit, the symptoms of dengue tend to stand apart from the other two, while influenza and COVID-19 symptoms are quite similar to each other.
| At the First Visit | Influenza | COVID-19 | Dengue |
|---|---|---|---|
| Cough and runny nose | Common | Common | Uncommon |
| Headache and body ache | Common | Common | Marked, often with pain behind the eyes |
| Joint pain and rash | Less frequent | Less frequent | More frequent |
| Nausea or vomiting | Uncommon | Uncommon | Frequent |
| Breathlessness | Uncommon | Possible | Only in severe disease |
A Singapore study of 477 reverse transcriptase polymerase chain reaction (RT-PCR) test confirmed patients, all seen within five days of onset, support the pattern shown above. Cough was present in 24% of dengue patients against 65% in COVID-19 and 81% in influenza, while headache was reported by 85% in dengue against 10% and 17%. Overall, the study indicates a pattern in which dengue leans towards headache, body ache and nausea with little cough, while influenza and COVID-19 both lean towards cough and a runny nose, and are hard to separate on symptoms alone.
However, this study is based on COVID-19 patients from early 2020, influenza patients from the 2009 pandemic, and dengue cases that were mostly serotype 2. Therefore, the numbers should be read for the pattern they show and not as exact figures.
Read Also: The Future of Robotic Surgery in India – Is Specializing in Worth It?
The difference between flu and COVID symptoms is less pronounced than the gap between either of them and dengue. A sudden high fever with nasal discharge points more to influenza, whereas shortness of breath and diarrhoea point more to COVID-19. Loss of smell or taste supports COVID-19 when it is present, but it has become less consistent. However, a diagnosis cannot be made solely on the symptoms, since the overlap is considerable, and testing remains the deciding step.
Onset offers a modest additional clue, since influenza typically begins abruptly, often within hours, while COVID-19 is more variable and has a slightly longer incubation, with a median of four to five days.
Contact history and vaccination status often weigh more than any single symptom. A pulse oximeter reading is worth recording at the first visit, since patients often underreport how breathless they are, and fever can be absent in a fair share of COVID-19 patients, so COVID-19 symptoms without fever should not lower the suspicion by themselves.
Dengue is easily overlooked when cough and coryza are absent and the patient’s symptoms are present like any other viral fever. During a situation like this, blood count often helps more than the history of the patient. Dengue typically brings leucopenia and a progressive fall in platelets, usually from around day 3 or 4, and the liver enzymes are frequently raised, with AST (Aspartate Aminotransferase, formerly known as SGOT) higher than ALT (Alanine Aminotransferase, formerly called SGPT) .
Influenza and COVID-19, by contrast, usually leave the platelet count normal or only mildly reduced. These are supportive findings and none is diagnostic on its own, but together with a fever and little or no cough they make dengue more likely. The counts may still be normal on day one or two, though, because the early symptoms of dengue can come before the counts fall, and a repeat Complete Blood Count (CBC) is reasonable if the fever continues.
Among flu, covid and dengue, dengue is the one that tends to worsen as the fever falls. The critical phase usually arrives with defervescence, somewhere between day 3 and day 7, and lasts a day or two. The WHO warning signs are abdominal pain or tenderness, persistent vomiting, mucosal bleeding, lethargy or restlessness, fluid accumulation, liver enlargement, and a rising haematocrit with a fast fall in platelets. A patient whose dengue fever symptoms seem to be easing at this point needs review, not reassurance.
For testing, NS1 antigen or a molecular test suits the first week, and IgM antibodies become detectable after 4 to 5 days from symptom onset and can remain detectable for up to about three months. COVID-19 and influenza are confirmed on respiratory samples, by RT-PCR or by rapid antigen testing. False-positive dengue serology has been reported in COVID-19 patients, and co-infections have also been described, so an isolated IgM in a patient with respiratory features deserves caution.
Flu symptoms that begin abruptly, in a patient at risk of complications, are usually reason enough to start an antiviral from the neuraminidase inhibitor class, since the benefit is greatest when it is given within the first 48 hours.
COVID-19 antiviral therapy is mainly reserved for patients at higher risk of severe disease and should be initiated as early as possible, generally within five to seven days of symptom onset, depending on the treatment used. Most other patients need supportive care and monitoring.
Dengue is managed differently, because there is no antiviral for it and treatment rests on fluids, close monitoring and paracetamol, while NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) are best avoided given the bleeding risk. Antibiotics do not change the course of influenza, COVID-19 or dengue, and are reserved for a bacterial complication. Because other fevers circulate at the same time of year, malaria, typhoid, scrub typhus and chikungunya also need to stay on the differential diagnosis list.
Flu, COVID and dengue prevention rests on different measures for each infection. For influenza and COVID-19, vaccination in eligible and high-risk patients is the main protection, supported by masking and ventilation while a person is symptomatic, whereas dengue depends largely on vector control, since the mosquito breeds in and around homes.
Recognising any of these infections at the earliest benefits the patient, and it also adds value to the doctor’s own practice. Continuing professional development therefore matters, as clinical guidelines and medicine keep evolving. Short programmes such as the fellowship and certificate courses at MediCOLL Learning can help doctors stay current and manage such patients with greater confidence.
Dengue vs Viral Fever Symptoms often do not differ clinically. A common viral fever tends to bring coryza, sore throat and cough, while dengue is more likely with severe headache, myalgia, joint pain and nausea and little respiratory involvement. Blood tests like CBC when shows decrease in white cells and platelets that favours dengue.
When loss of smell is present it can point towards COVID-19. But it is now less consistent than earlier in the pandemic, so the absence of it doesn’t exclude the infection.
Distinguishing between seasonal flu and COVID-19 by symptoms alone is difficult, because they share many features such as fever, cough, body aches and fatigue. Testing is needed to confirm the diagnosis.
Yes, Co-infection has been reported in some cases. When respiratory symptoms are present together with leucopenia and thrombocytopenia, it is a reason to test for both. A positive dengue IgM in such a patient should be interpreted carefully, given the possible cross-reactivity.
Common symptoms of COVID-19 are fever or chills, cough, shortness of breath, sore throat, congestion or runny nose, loss of taste or smell, fatigue or extreme tiredness, body aches, headache and gastrointestinal symptoms such as nausea, vomiting, or diarrhoea. Elderly
© Copyrights Medicoll All rights reserved.
